miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.

Neuro-oncology
Wei ZhangClark C Chen

Abstract

Genome-wide microRNA (miRNA) profiling of 82 glioblastomas demonstrated that miR-181d was inversely associated with patient overall survival after correcting for age, Karnofsky performance status, extent of resection, and temozolomide (TMZ) treatment. This association was validated using the Cancer Genome Atlas (TCGA) dataset (n= 424) and an independent cohort (n= 35). In these independent cohorts, an association of miR-181d with survival was evident in patients who underwent TMZ treatment but was not observed in patients without TMZ therapy. Bioinformatic analysis of potential genes regulated by miR-181d revealed methyl-guanine-methyl-transferase (MGMT) as a downstream target. Indeed, transfection of miR-181d downregulated MGMT mRNA and protein expression. Furthermore, luciferase reporter assays and coprecipitation studies showed a direct interaction between miR-181d and MGMT 3'UTR. The suppressive effect of miR-181d on MGMT expression was rescued by the introduction of an MGMT cDNA. Finally, MGMT expression inversely correlated with miR-181d expression in independent glioblastoma cohorts. Together, these results suggest that miR-181d is a predictive biomarker for TMZ response and that its role is mediated, in part, by posttra...Continue Reading

References

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K TanoS Mitra
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B DempleT Lindahl
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Jul 7, 2007·Molecular Cell·Andrew GrimsonDavid P Bartel
Nov 28, 2007·Annual Review of Pathology·David N Louis
Sep 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monika E HegiMark R Gilbert
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 30, 2009·PloS One·Derek M DykxhoornJudy Lieberman

❮ Previous
Next ❯

Citations

Jan 22, 2013·Cellular and Molecular Neurobiology·Panagiotis J VlachostergiosChristos N Papandreou
May 7, 2013·Investigational New Drugs·Panagiotis J VlachostergiosChristos N Papandreou
Apr 30, 2013·Molecular Neurobiology·Amanda Tivnan, Kerrie Leanne McDonald
Apr 10, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Andrej BesseOndrej Slaby
Oct 23, 2013·Trends in Molecular Medicine·Irfan A Qureshi, Mark F Mehler
Oct 23, 2013·PloS One·Cristina QuintavalleGerolama Condorelli
Mar 1, 2013·CNS Oncology·Yin Yee Sharon Low, Wai Hoe Ng
Jun 11, 2014·Nature Reviews. Neurology·Wolfgang WickGuido Reifenberger
Apr 4, 2014·Molecular Neurobiology·Charlotte A TumilsonLisa Shaw
Jun 5, 2016·Biochemistry. Biokhimii︠a︡·A A StavrovskayaE Yu Rybalkina
Aug 7, 2014·Expert Review of Molecular Diagnostics·Emeline TabouretAhmed Idbaih
Jun 3, 2015·International Journal of Oncology·Giulio CabriniRoberto Gambari
Jul 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tao TaoYongping You
Sep 19, 2012·Pharmacology & Therapeutics·H F van ThuijlJ C Reijneveld
Mar 12, 2016·Cancer Letters·Tao JiangUNKNOWN Chinese Glioma Cooperative Group (CGCG)
Mar 13, 2015·Molecular Carcinogenesis·Weiguang ZhangShiguang Zhao
Sep 16, 2015·Nature Reviews. Neurology·Manfred Westphal, Katrin Lamszus
Dec 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hong-jun WangChuan-lu Jiang
May 10, 2015·The American Journal of Pathology·Ze-Hua ZuoJian-Hua Luo
Apr 24, 2015·Journal of Neuro-oncology·Johnny C AkersClark C Chen
May 7, 2013·Neuroscience Letters·Yanwei LiuWei Zhang
Apr 10, 2014·Frontiers in Oncology·Harry R HaynesKathreena M Kurian
Jun 11, 2016·Cancer Medicine·Amanda SheaDeepak Kumar
Jun 12, 2016·Briefings in Functional Genomics·Veronique G LeBlanc, Marco A Marra
Aug 21, 2016·Mutation Research. Reviews in Mutation Research·Hélène ErasimusEric Van Dyck
Jun 30, 2016·Endocrine-related Cancer·J CrosA Couvelard
Apr 12, 2016·Cancer Biomarkers : Section a of Disease Markers·Johnny C AkersClark C Chen
Oct 14, 2016·Scientific Reports·Daeyong Jin, Hyunju Lee
Feb 18, 2016·Journal of Neuropathology and Experimental Neurology·Lasse S KristensenHelle Broholm
Mar 2, 2016·International Journal of Molecular Sciences·Víctor MicóLidia Daimiel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.